Filing Details

Accession Number:
0000899243-20-030132
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-02 20:39:52
Reporting Period:
2020-10-30
Accepted Time:
2020-11-02 20:39:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1791091 Healthcare Merger Corp. HCCO () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1453072 Alyeska Investment Group, L.p. 77 West Wacker Drive, 7Th Floor
Chicago IL 60601
No No Yes No
1456506 Alyeska Master Fund, L.p. 77 West Wacker Drive, 7Th Floor
Chicago IL 60601
No No Yes No
1775953 Alyeska Master Fund 3, L.p. 77 West Wacker Drive, 7Th Floor
Chicago IL 60601
No No Yes No
1822280 Anand Parekh 77 West Wacker Drive, 7Th Floor
Chicago IL 60601
No No Yes No
1822281 Alyeska Investments, Llc 77 West Wacker Drive, 7Th Floor
Chicago IL 60601
No No Yes No
1822286 Alyeska Investment Group, Llc 77 West Wacker Drive, 7Th Floor
Chicago IL 60601
No No Yes No
1822287 Alyeska Fund Gp, Llc 77 West Wacker Drive, 7Th Floor
Chicago IL 60601
No No Yes No
1822509 Alyeska Fund 3 Gp, Llc 77 West Wacker Drive, 7Th Floor
Chicago IL 60601
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2020-10-30 25,000 $9.04 3,125,000 No 4 P Direct
Class A Common Stock Acquisiton 2020-10-30 24,801 $9.04 3,100,196 No 4 P Direct
Class A Common Stock Acquisiton 2020-10-30 199 $9.04 24,804 No 4 P Direct
Class A Common Stock Acquisiton 2020-10-30 24,801 $9.04 3,100,196 No 4 P Indirect Footnotes
Class A Common Stock Acquisiton 2020-10-30 199 $9.04 24,804 No 4 P Indirect Footnotes
Class A Common Stock Acquisiton 2020-10-30 25,000 $9.04 3,125,000 No 4 P Indirect Footnotes
Class A Common Stock Acquisiton 2020-10-30 25,000 $9.04 3,125,000 No 4 P Indirect Footnotes
Class A Common Stock Acquisiton 2020-10-30 25,000 $9.04 3,125,000 No 4 P Indirect Footnotes
Class A Common Stock Acquisiton 2020-10-30 25,000 $9.05 3,150,000 No 4 P Direct
Class A Common Stock Acquisiton 2020-10-30 24,802 $9.05 3,124,998 No 4 P Direct
Class A Common Stock Acquisiton 2020-10-30 198 $9.05 25,002 No 4 P Direct
Class A Common Stock Acquisiton 2020-10-30 24,802 $9.05 3,124,998 No 4 P Indirect Footnotes
Class A Common Stock Acquisiton 2020-10-30 198 $9.05 25,002 No 4 P Indirect Footnotes
Class A Common Stock Acquisiton 2020-10-30 25,000 $9.05 3,150,000 No 4 P Indirect Footnotes
Class A Common Stock Acquisiton 2020-10-30 25,000 $9.05 3,150,000 No 4 P Indirect Footnotes
Class A Common Stock Acquisiton 2020-10-30 25,000 $9.05 3,150,000 No 4 P Indirect Footnotes
Class A Common Stock Acquisiton 2020-10-30 25,000 $9.09 3,175,000 No 4 P Direct
Class A Common Stock Acquisiton 2020-10-30 24,802 $9.09 3,149,800 No 4 P Direct
Class A Common Stock Acquisiton 2020-10-30 198 $9.09 25,200 No 4 P Direct
Class A Common Stock Acquisiton 2020-10-30 24,802 $9.09 3,149,800 No 4 P Indirect Footnotes
Class A Common Stock Acquisiton 2020-10-30 198 $9.09 25,200 No 4 P Indirect Footnotes
Class A Common Stock Acquisiton 2020-10-30 25,000 $9.09 3,175,000 No 4 P Indirect Footnotes
Class A Common Stock Acquisiton 2020-10-30 25,000 $9.09 3,175,000 No 4 P Indirect Footnotes
Class A Common Stock Acquisiton 2020-10-30 25,000 $9.09 3,175,000 No 4 P Indirect Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Indirect Footnotes
No 4 P Indirect Footnotes
No 4 P Indirect Footnotes
No 4 P Indirect Footnotes
No 4 P Indirect Footnotes
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Indirect Footnotes
No 4 P Indirect Footnotes
No 4 P Indirect Footnotes
No 4 P Indirect Footnotes
No 4 P Indirect Footnotes
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Indirect Footnotes
No 4 P Indirect Footnotes
No 4 P Indirect Footnotes
No 4 P Indirect Footnotes
No 4 P Indirect Footnotes
Footnotes
  1. Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,174,601 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 25,399 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares.
  2. (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds.
  3. The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest.
  4. On October 30, 2020, Fund 1 purchased 24,801, 24,802, 24,802 and 24,801 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively, and Fund 3 purchased 199, 198, 198 and 199 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively.
  5. The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. The Form 4 for certain additional transactions is being filed separately and simultaneously with this Form 4 due to the limitation of 30 rows in Table I.